Skip to content
Menu
Ranked #344

Signos

Signos (Signos+) is a metabolic-health platform that bundles clinician-prescribed compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor (CGM) and app.

Desk Score 62/100 (C) · Verified July 2026

Visit SignosAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way.

Is Signos legit?

Only what Signos publishes and what we could check ourselves — nothing inferred. See the methodology.

Certification
On third-party certification, the site doesn't say.
Where it ships
The site doesn't say which states it serves.
Last checked
July 2026, against Signos's own pages.
Published price
Signos publishes a figure for semaglutide and tirzepatide — the qualifiers are in "What does Signos cost?" below.
What it sells
Compounded medication only, injectable route only.
Licensing & trust
78/100 on the scored dimension of that name — one of the six in our published methodology.

Checks out as far as the figures go, with one caveat: every price Signos publishes carries a condition, so the number on the site is not the monthly bill.

What does Signos cost?

Each figure exactly as Signos publishes it, with the condition attached to it spelled out.

Semaglutide

$199/mo (6-month plan, compounded)

That is a prepay rate: $199 a month applies only if the whole term is paid up front, so the charge on your card is larger than the monthly number.

Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for semaglutide — only flat month-to-month rates compete there.

Tirzepatide

$199/mo (starting dose, compounded)

That is a starting figure, not the price at every dose: $199 a month is the lowest rung, and the cost rises from there.

Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for tirzepatide — only flat month-to-month rates compete there.

All figures as published on Signos's own site and read in July 2026. Prices change — confirm before you order.

Semaglutide
$199/mo6-month prepay
Tirzepatide
From $199/molowest dose rung
Coverage
Not listed on Signos's site (checked July 2026)
Brand-name
Compounded only
Verification
Prices as published on Signos's site — verified july 2026. Each figure's full condition is in “What does Signos cost?” below.

Weigh Signos against the full ranked field on the best semaglutide providers ranking, or line it up against its closest alternatives. Or go one-on-one: Signos vs CoreAge Rx. Because Signos dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency68/100
State access24/100
Molecule range66/100
Onboarding speed72/100
Support responsiveness82/100
Licensing & trust78/100

What we like

  • Bundles compounded GLP-1 (semaglutide) with an FDA-cleared CGM and app — glucose-guided weight loss, not just medication
  • Starting at $199/mo on a 6-month program, with the CGM included at no extra cost
  • Free rapid shipping; HSA/FSA eligible
  • Real-time glucose insights and app coaching to help sustain results after GLP-1

Where points come off

  • Compounded GLP-1s are not FDA-approved finished products
  • Headline price is a 6-month-program rate, not month-to-month
  • Only semaglutide is shown in the program; tirzepatide availability is not confirmed
  • Compounding pharmacy partner and state availability are not published on the landing page

The bottom line — C

Best for: Pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app.

Signos ranks #344 of 542 providers scored — see #1, CoreAge Rx here.

Related reviews

Everyone else here (18)

Pricing and verification reflect Signos's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Signos's site. Not medical advice; see our disclosure.

← Back to the ranking